Novel germline CDH1 mutations in hereditary diffuse gastric cancer families

被引:53
作者
Humar, B
Toro, T
Graziano, F
Müller, H
Dobbie, Z
Kwang-Yang, H
Eng, C
Hampel, H
Gilbert, D
Winship, I
Parry, S
Ward, R
Findlay, M
Christian, A
Tucker, M
Tucker, K
Merriman, T
Guilford, P
机构
[1] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, Aotearoa, New Zealand
[2] Hosp Urbino, Div Med Oncol, Urbino, Italy
[3] Dept Clin & Biol Sci, Div Med Genet, Basel, Switzerland
[4] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[5] Ohio State Univ, Ctr Comprehens Canc, Clin Canc Genet Program, Columbus, OH 43210 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA
[7] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA
[8] Auckland Hosp, No Reg Genet Serv, Auckland, New Zealand
[9] Middlemore Hosp, Auckland 6, New Zealand
[10] St Vincents Hosp, Darlinghurst, NSW 2010, Australia
[11] Wellington Hosp, Wellington Canc Ctr, Wellington, New Zealand
[12] Wellington Hosp, Cent Reg Genet Serv, Wellington, New Zealand
[13] Prince Wales Hosp, Randwick, NSW 2031, Australia
[14] Univ Otago, Dept Biochem, Dunedin, New Zealand
关键词
hereditary diffuse gastric cancer; HDGC; E-cadherin; CDH1; germline;
D O I
10.1002/humu.10067
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary diffuse gastric cancer (HDGC) is a recently defined cancer syndrome caused by inactivating, heterozygous germline mutations in the gene for the cell,to cell adhesion protein E-cadherin (CDH1). Here, we describe the search for CDH1 mutations in 10 newly identified gastric cancer families. Seven of 10 families met the clinical criteria for HDGC.. Germline mutations were identified in four of these seven families and one family that was borderline for the clinical criteria. Of the mutations identified in the five new families, four were previously unreported and consisted of two frameshift and two donor splice site mutations. One splice site mutation occurred at the 100% conserved +1 position. The second splice site mutation occurred at the +5 position and was shown to lead to abnormal splicing. Additional CDH1 variants detected include the heterozygous -160 C-->A promoter polymorphism, which has previously been reported to be associated with decreased CDH1 transcription. We, however, found this polymorphism to be common in a control population, suggesting that a major role for this polymorphism in gastric cancer susceptibility is unlikely.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 23 条
[1]   E-cadherin is not frequently mutated in hereditary gastric cancer [J].
Avizienyte, E ;
Launonen, V ;
Salovaara, R ;
Kiviluoto, T ;
Aaltonen, LA .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (01) :49-52
[2]  
BECKER KF, 1994, CANCER RES, V54, P3845
[3]  
Caldas C, 1999, J MED GENET, V36, P873
[4]   Hereditary diffuse gastric cancer [J].
Dunbier, A ;
Guilford, P .
ADVANCES IN CANCER RESEARCH, VOL 83, 2001, 83 :55-65
[5]   A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination [J].
Dussaulx-Garin, L ;
Blayau, M ;
Pagenault, M ;
Le Berre-Heresbach, N ;
Raoul, JL ;
Campion, JP ;
David, V ;
Bretagne, JF .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (06) :711-715
[6]   Genetic testing for breast cancer susceptibility:: Frequency of BRCA1 and BRCA2 mutations [J].
Ganguly, A ;
Leahy, K ;
Marshall, AM ;
Dhulipala, R ;
Godmilow, L ;
Ganguly, T .
GENETIC TESTING, 1997, 1 (02) :85-90
[7]  
Gayther SA, 1998, CANCER RES, V58, P4086
[8]   E-cadherin germline mutations in familial gastric cancer [J].
Guilford, P ;
Hopkins, J ;
Harraway, J ;
McLeod, M ;
McLeod, N ;
Harawira, P ;
Taite, H ;
Scoular, R ;
Miller, A ;
Reeve, AE .
NATURE, 1998, 392 (6674) :402-405
[9]  
Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO
[10]  
2-9